U.S., Sept. 15 -- ClinicalTrials.gov registry received information related to the study (NCT07817134) titled 'A Study to Visualize Multi-Symptom Allergy in Adults With Seasonal Allergic Rhinitis' on Aug. 31.
Brief Summary: This study is designed to visualize the response to use of fluticasone propionate nasal spray (Flonase Allergy Relief) to relieve facial allergy symptoms in individuals with moderate to severe seasonal allergic rhinitis (SAR).
Study Start Date: Sept., 2026
Study Type: INTERVENTIONAL
Condition:
Rhinitis Allergic
Rhinitis Seasonal
Intervention:
DRUG: Fluticasone propionate
Fluticasone propionate aqueous nasal spray (United States Pharmacopeia [USP]), 50 microgram (mcg)/metered spray.
Recruitment Status: NOT_YET_REC...